These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38621197)

  • 21. Germline mutations in homologous recombination repair genes among Chinese pancreatic ductal adenocarcinoma patients detected using next-generation sequencing.
    Jiang H; Huang F; Chen X; Zhang L; Shen M; Pan B; Wang B; Guo W
    Mol Genet Genomic Med; 2023 Jul; 11(7):e2170. PubMed ID: 36978154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BRCA1 and BRCA2 germline mutations are frequently demonstrated in both high-risk pancreatic cancer screening and pancreatic cancer cohorts.
    Lucas AL; Frado LE; Hwang C; Kumar S; Khanna LG; Levinson EJ; Chabot JA; Chung WK; Frucht H
    Cancer; 2014 Jul; 120(13):1960-7. PubMed ID: 24737347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluating implementation of NCCN guideline-directed genetic screening recommendations for patients with pancreatic ductal adenocarcinoma.
    Ghosh AK; Bhushan S; Abidoye O; Robinson SS; Rynarzewska AI; Sampat D
    Cancer Causes Control; 2024 Apr; 35(4):679-684. PubMed ID: 38015388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pancreatic Cancer Surveillance in Carriers of a Germline
    Klatte DCF; Boekestijn B; Wasser MNJM; Feshtali Shahbazi S; Ibrahim IS; Mieog JSD; Luelmo SAC; Morreau H; Potjer TP; Inderson A; Boonstra JJ; Dekker FW; Vasen HFA; van Hooft JE; Bonsing BA; van Leerdam ME
    J Clin Oncol; 2022 Oct; 40(28):3267-3277. PubMed ID: 35658523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic assessment of pathogenic germline alterations in lysosomal genes among Asian patients with pancreatic ductal adenocarcinoma.
    Koh Y; Kim H; Joo SY; Song S; Choi YH; Kim HR; Moon B; Byun J; Hong J; Shin DY; Park S; Lee KH; Lee KT; Lee JK; Park D; Lee SH; Jang JY; Lee H; Kim JA; Yoon SS; Park JK
    J Transl Med; 2023 Oct; 21(1):730. PubMed ID: 37848935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CDKN2A founder mutation in pancreatic ductal adenocarcinoma patients without cutaneous features of Familial Atypical Multiple Mole Melanoma (FAMMM) syndrome.
    Cremin C; Howard S; Le L; Karsan A; Schaeffer DF; Renouf D; Schrader KA
    Hered Cancer Clin Pract; 2018; 16():7. PubMed ID: 29541281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of pancreaticobiliary cancers in Irish families with pathogenic BRCA1 and BRCA2 variants.
    Power R; Leavy C; Nolan C; White N; Clarke R; Cadoo KA; Gallagher DJ; Lowery MA
    Fam Cancer; 2021 Apr; 20(2):97-101. PubMed ID: 32918181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Germline BRCA mutations in Asian patients with pancreatic adenocarcinoma: a prospective study evaluating risk category for genetic testing.
    Lee K; Yoo C; Kim KP; Park KJ; Chang HM; Kim TW; Lee JL; Lee W; Lee SS; Park DH; Song TJ; Seo DW; Lee SK; Kim MH; Shin SH; Hwang DW; Song KB; Lee JH; Kim SC; Ryoo BY
    Invest New Drugs; 2018 Feb; 36(1):163-169. PubMed ID: 28782087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surveillance for Pancreatic Cancer in High-Risk Individuals Leads to Improved Outcomes: A Propensity Score-Matched Analysis.
    Klatte DCF; Boekestijn B; Onnekink AM; Dekker FW; van der Geest LG; Wasser MNJM; Feshtali S; Mieog JSD; Luelmo SAC; Morreau H; Potjer TP; Inderson A; Boonstra JJ; Vasen HFA; van Hooft JE; Bonsing BA; van Leerdam ME;
    Gastroenterology; 2023 Jun; 164(7):1223-1231.e4. PubMed ID: 36889551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating Tumor DNA-Based Testing and Actionable Findings in Patients with Advanced and Metastatic Pancreatic Adenocarcinoma.
    Botrus G; Kosirorek H; Sonbol MB; Kusne Y; Uson Junior PLS; Borad MJ; Ahn DH; Kasi PM; Drusbosky LM; Dada H; Surapaneni PK; Starr J; Ritter A; McMillan J; Wylie N; Mody K; Bekaii-Saab TS
    Oncologist; 2021 Jul; 26(7):569-578. PubMed ID: 33555095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer surveillance awareness and practice among families at increased risk for pancreatic adenocarcinoma.
    Everett JN; Burgos G; Chun J; Baptiste A; Khanna LG; Oberstein PE; Simeone DM
    Cancer; 2021 Jul; 127(13):2271-2278. PubMed ID: 33721345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contribution of a Circulating 2'-O-methylated MicroRNA Panel to the Diagnosis of Pancreatic Ductal Adenocarcinoma.
    Yang Z; Huang J; Wu X; Zhou Y; Tang Y; Zhu Y; Li B; Chen X; Yao W
    J Cancer; 2024; 15(6):1583-1592. PubMed ID: 38370369
    [No Abstract]   [Full Text] [Related]  

  • 33. Inherited predisposition to pancreatic cancer.
    Hilfrank KJ; Rustgi SD; Kastrinos F
    Semin Oncol; 2021 Feb; 48(1):2-9. PubMed ID: 33773812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part I, AJCC staging system, NCCN guidelines, and borderline resectable disease.
    Kulkarni NM; Soloff EV; Tolat PP; Sangster GP; Fleming JB; Brook OR; Wang ZJ; Hecht EM; Zins M; Bhosale PR; Arif-Tiwari H; Mannelli L; Kambadakone AR; Tamm EP
    Abdom Radiol (NY); 2020 Mar; 45(3):716-728. PubMed ID: 31748823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Referral frequency, attrition rate, and outcomes of germline testing in patients with pancreatic adenocarcinoma.
    Walker EJ; Carnevale J; Pedley C; Blanco A; Chan S; Collisson EA; Tempero MA; Ko AH
    Fam Cancer; 2019 Apr; 18(2):241-251. PubMed ID: 30267352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. State-to-State Variation in Opioid Dispensing Changes Following the Release of the 2016 CDC Guideline for Prescribing Opioids for Chronic Pain.
    Lyu X; Guy GP; Baldwin GT; Losby JL; Bohnert ASB; Goldstick JE
    JAMA Netw Open; 2023 Sep; 6(9):e2332507. PubMed ID: 37695587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid Progression of Metastatic Pancreatic Adenocarcinoma During Platinum-Based Therapy in a Patient Harboring a Pathogenic BRCA2 Germline Variant.
    Sorscher S; Ramkissoon S
    Oncologist; 2021 Nov; 26(11):916-918. PubMed ID: 34309133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular Characterization of Pancreatic Ductal Adenocarcinoma Using a Next-Generation Sequencing Custom-Designed Multigene Panel.
    Malvi D; Vasuri F; Maloberti T; Sanza V; De Leo A; Fornelli A; Masetti M; Benini C; Lombardi R; Offi MF; Di Marco M; Ravaioli M; Fiorino S; Franceschi E; Brandes AA; Jovine E; D'Errico A; Tallini G; de Biase D
    Diagnostics (Basel); 2022 Apr; 12(5):. PubMed ID: 35626213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Multicenter Cancer of Pancreas Screening Study: Impact on Stage and Survival.
    Dbouk M; Katona BW; Brand RE; Chak A; Syngal S; Farrell JJ; Kastrinos F; Stoffel EM; Blackford AL; Rustgi AK; Dudley B; Lee LS; Chhoda A; Kwon R; Ginsberg GG; Klein AP; Kamel I; Hruban RH; He J; Shin EJ; Lennon AM; Canto MI; Goggins M
    J Clin Oncol; 2022 Oct; 40(28):3257-3266. PubMed ID: 35704792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of Germline Sequence Variations Among Patients With Pancreatic Cancer in China.
    Yin L; Wei J; Lu Z; Huang S; Gao H; Chen J; Guo F; Tu M; Xiao B; Xi C; Zhang K; Li Q; Wu J; Gao W; Jiang K; Yu J; Miao Y
    JAMA Netw Open; 2022 Feb; 5(2):e2148721. PubMed ID: 35171259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.